Followers | 130 |
Posts | 18112 |
Boards Moderated | 0 |
Alias Born | 01/16/2007 |
Saturday, July 01, 2017 6:02:21 AM
11 Reasons HHSE/CRIM/Newco Stock Continues Increasing Post MERGER
5.) Artificial Manipulation, Stock Price Boxing Completion/Exhausted
Item 8.01 b.)
https://www.sec.gov/Archives/edgar/data/1069680/000147124215000077/hhse8k09252015.htm
The manipulators big mistake? They picked the wrong company. Rather than choosing a worthless company headed for zero, they chose a credible growing, valuable company headed for NASDAQ. HHSE CEO is a proven, trustworthy, hard-working, widely respected industry veteran with much experience.
Pre-MERGER HHSE is fairly valued north of .10. Enhanced Theatrical Slate, including top shelf Productions "Mother Goose: Journey To Utopia" and Meltdown". VODWIZ Launch. No Dilution. HHSE Post-MERGER probably valued at about .30 or more. The imminent NASDAQ Uplisting is the final nail in the manipulators coffin. The increasing Revenues/Profits plus growing informed investor base just too much to deny HHSE.
See HHSE Charts for visual verification:
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=129859844
11 REASONS HHSE/CRIM/NEWCO STOCK PRICE CONTINUES INCREASING POST MERGER
1.) Multiple Legal Issue Settlements
2.) Launch VODwiz
3.) Increased Revenues / Earnings
4.) HHSE/CRIM/Newco Uplist NASDAQ Stock Exchange
5.) Artificial Manipulation, Stock Price Boxing Completion/Exhausted
6.) 5 Significant Media Players (Chinese Based) Conduct Various Post MERGER Financial Transactions ($65,000,000 Funding)
7.) $4,000,000 HHSE/CRIM/Newco Direct Stock Purchase @ 100% Premium (Major Media Company)
8.) HHSE/CRIM/Newco Share Support. Contemporaneous with the merger, several of the China-based affiliates will be buying blocks of Crimson stock on the public markets
Additionally, Post MERGER HHSE/CRIM Embark on three, very exciting new distribution ventures that post merger activities will have a dramatic impact on the company's revenues, visibility and valuation, involving:
9.) North American Activities
10.) International Sales
11.) Theatrical Distribution In China
HHSE
Recent HHSE News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 07:17:02 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM